Return to Listing

1 result(s) for Cymbalta

PI Name Protocol # Title
Kathleen Kemmer IRB00010502 A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer
For more information:
Call: 503-494-1080

You may qualify for additional trials within our Phase 1 Program